This inventor holds 5 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 3 EPO patents. Top assignees: Nextgen Bioscience Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Sk Chemicals Co., Ltd.. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
1 out of 77 
1 out of 201 
Years Active: 2015-2024
Title: Bong Yong Lee: Innovator in Pharmaceutical Composition
Introduction
Bong Yong Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target various diseases. With a total of 5 patents, his work has the potential to impact the treatment of numerous health conditions.
Latest Patents
One of his latest patents is a piperidine derivative and pharmaceutical composition for inhibiting autotaxin. This invention provides a piperidine derivative compound, which exhibits excellent inhibitory activity against autotaxin. It can be effectively used in the treatment and prevention of diseases related to autotaxin inhibition, such as fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer and cancer metastasis, ocular diseases, cholestatic form and other forms of chronic pruritus, and acute or chronic organ transplant rejection. Another notable patent is a pharmaceutical composition for preventing or treating inflammatory bowel disease, which acts as a functional antagonist for S1PR1 and S1PR4. This composition includes a sphingolipid compound that does not cause cardiovascular side effects and has shown effectiveness in preventing or treating inflammatory bowel disease.
Career Highlights
Bong Yong Lee has worked with notable companies in the pharmaceutical industry, including Nextgen Bioscience Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Throughout his career, Bong Yong Lee has collaborated with talented individuals such as Eun Jeong Kim and Yang Hae Park. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Bong Yong Lee is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform the treatment landscape for various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile